Viridian Therapeutics Ors Shs's chart data is dated 2026-10-08. There is no active technical signal. There are 1 published signal records.
Viridian Therapeutics Ors Shs last closed at $18.34 (+0.33%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is -5.1×. Its overall grade ranks 503 of 738 stocks in Healthcare.
About this company
Viridian Therapeutics Ors Shs last closed at $18.34 (+0.33%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C+ · 503/738
Valuation grade B-
Related stocks
- RocheCompetitor
안구질환 치료제 시장에서 VRDN의 TED/안과 파이프라인과 경쟁하는 대형 제약사
- AmgenCompetitor
희귀안질환·염증성 질환 영역에서 신약 경쟁 구도를 형성하는 대형 바이오
- Johnson & JohnsonCompetitor
면역·안과 치료제 분야에서 경쟁 가능한 글로벌 제약사
ETFs holding this stock
iShares Micro-Cap ETF
Details →About Viridian Therapeutics Ors Shs
- What technical signals does Viridian Therapeutics Ors Shs (VRDN) have?
- Viridian Therapeutics Ors Shs current technical signals: no active technical signal.
- Is Viridian Therapeutics Ors Shs a cup-and-handle pattern?
- No. Viridian Therapeutics Ors Shs has no valid Cup signal right now.
- What published figures are available for Viridian Therapeutics Ors Shs?
- Market cap: $1.75B. Trailing 12 months PER: -5.1×. Latest quarter PBR: 2.99×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Viridian Therapeutics Ors Shs, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.